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Gap Title Description Gap Decomposition Questions 
1.01 Inadequate and/or immature 
information on medical 
screening technologies for the 
identification of clinical and 
subclinical pathology for 
medical conditions experienced 
in space flight environments 
This is an ongoing gap that the element will continually 
address.  There are no plans to close this gap. Both 
genetic and phenotypic screening will be addressed by 
this gap. 
 What new screening technologies are 
available? 
 What genetic screening techniques are 
in clinical trials or being researched? 
2.01 Lack of knowledge about 
incidence rates, probabilities, 
and consequences relative to 
Loss of Crew and/or Loss of 
Mission (LOC/LOM) for the 
medical conditions on the 
Exploration Medical Condition 
List 
One of the major gaps of knowledge in space medicine 
is quantification of likelihood and consequence of 
medical conditions that could occur during space flight.  
The total combined duration of human space flight is 
brief and limited.  So the body of medical evidence 
from which to quantify medical conditions is small 
when compared to the terrestrial medicine body of 
evidence. 
 
The focus of this gap is to generate a list of medical 
conditions that are of concern for human space flight, 
and provide quantifiable data and rationale about why 
the medical condition is of concern. 
 How should consequence of a medical 
condition be factored in with the 
incidence rate of the medical condition? 
2.02 Lack of quantitative knowledge 
about impact of having a 
clinically trained crew medical 
officer on each space flight 
mission 
It has not been quantified yet if inclusion of a physician 
crewmember with relevant competency maintained 
over the exploration mission would achieve better 
care/reduced risk, reduced cost, reduced training time, 
increased efficiency, reduced need for telementoring 
and increased autonomy.  This gap aims to determine 
what effect a clinically trained crewmember would 
have on overall cost and medical care quality. 
 How does the medical background of 
the Crew Medical Officer (CMO) affect 
crew health and mission end states?  
 What training and technology gaps exist 
for each level of clinically trained 
CMO?  
 Can one clinically trained CMO 
individually effectively manage a 
medical contingency? 
 For each medical condition, how many 




what level of support caregiver training 
is required, to manage a medical 
contingency?  
3.01 Lack of knowledge about 
effectiveness of current NASA 
medical training programs 
including crewmember and 
ground support in diagnosing 
and treating medical conditions 
for the best possible outcome 
Training of crewmembers and ground support teams is 
a critical component of a medical health care system.  
Providing medical hardware and technology is not 
enough when that equipment is not placed in the hands 
of a well trained and effective care provider.  This gap 
seeks to explore the effectiveness of current NASA 
medical training programs and document any 
inadequacies in those programs based on the many 
years of short- and long-duration manned space flights. 
 How effective are the medical training 
programs in enabling CMOs to execute 
and retain the skills to manage a 
medical event?  
 How effective are the training programs 
for ground personnel in supporting the 
CMO during a medical event? 
 What is the role of just-in-time training? 
3.02 Lack of knowledge about the 
current state of the art in 
telementoring/telemedicine as a 
tool for assisting crewmembers 
in  diagnosing and treating 
medical conditions that occur 
during space flight 
Telementoring is the delivery of training and mentoring 
services across telecommunication networks typically 
in the format of audio and video.  As a subset modality 
of telemedicine, telementoring is focused on providing 
a means to train operators with the instructor physically 
located in a remote location.  Based on the type of 
training content, the presentation format may vary.  
Various formats include teleconference, video 
conference, or web exchange.  Due to the relative 
novelty of this form of communication, telementoring 
has only recently started to gain momentum as a means 
of guiding and training remote operators.  As such, 
effective means of communicating and techniques to 
convey information are constantly being developed.  
This gap is focused on understanding the latest 
telementoring technologies and techniques, as well as 
media platforms on which the information is presented. 
Gap decomposition questions for this gap 
will be developed after the Telemedicine 
Summit in November 2010. 
3.03 Inadequate means and methods 
for early recognition of in-flight 
medical conditions (including 
behavioral and functional) that 
can lead to higher consequence 
outcomes if not treated early 
The prevention of medical conditions is the primary 
approach for having a healthy crew to perform a 
successful space flight mission.  Periodic in-flight 
health status exams and routine crew monitoring are 
used in the early recognition of certain conditions on 
the Exploration Medical Condition List.  By catching 
these conditions early, fewer resources can be used to 
 What monitoring or screening 
technologies, techniques, or methods are 
needed to enable early recognition of 
each of the medical conditions? 
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treat the condition before it fully manifests into a 
potential worst-case scenario.  This gap looks at all the 
various techniques and methods that can be used to 
monitor the crew and enable early recognition of 
medical conditions that could impact mission success. 
4.01 Lack of autonomous medical 
procedure system that includes 
decision assistance and 
integrates with medical 
hardware including closed loop 
systems 
The current space flight procedure system is a 
combination of both paper and electronic formats.  The 
procedures themselves are developed and validated on 
the ground.  The burden is placed on the crewmember 
to collect, analyze, and interpret data to decide which 
procedural decision pathway to follow.  This can be an 
issue with medical procedures as the crewmembers 
often are not clinicians.  They are given minimal 
medical training often months before the start of their 
mission.  This gap focuses on reducing the burden of 
medical data analysis and decision making on the 
crewmember.  In addition, this system could be useful 
in supporting a physician crew medical officer and 
offering a secondary set of instructions or assistance for 
an augmented medical care giver.  An autonomous 
medical procedure system would assist the 
crewmember in analyzing and interpreting the medical 
data collected so that the proper decision pathways are 
followed. 
 How should information presentation 
and analysis of the data be tailored 
given the clinical skill level of the 
caregiver? 
 What technologies exist that can 
provide intuitive information to assist 
the care provider during a medical 
event? 
 What level of automation or 
"smartness" should be provided to the 
care provider given their level of 
medical expertise? 
4.02 Lack of noninvasive diagnostic 
imaging capability and 
techniques to diagnose identified 
Exploration Medical Conditions 
involving internal body parts 
 
Due to the normal constraints of space flight, most 
common clinical diagnostic techniques will not be 
available during exploration missions.  That is 
especially true for imaging diagnostics.  Although 
physicians commonly use X-rays, Computed 
Tomography (CT) scans, Magnetic Resonance Imaging 
(MRI), ultrasound, and other techniques, perhaps only 
ultrasound may be compatible with space flight.  Flight 
surgeons have requested improved imaging hardware 
operating in the visible portion of the electromagnetic 
spectrum to acquire digital images of skin and body 
orifices.  Work under this gap will initially focus on 
 How can the role of diagnostic imaging 
be expanded to monitor/facilitate 
treatment, determine countermeasure 
efficacy, predict patient medical 
outcomes, assess mission/crew safety 
risk, and assist with key mission 
planning decisions? 
 How can minimally trained flight crews 
obtain images of sufficient diagnostic 
quality, particularly given the organ 
shifts associated with spaceflight?  
 How can computationally intensive 
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identifying space flight medical conditions where 
imaging-based diagnosis and/or treatment is required, 
developing an evidence base for determining which 
technologies are required, and assessing the space 
flight readiness of the identified technologies. 
 
Once the appropriate technologies are identified and 
readiness determined, a plan will be developed to not 
only integrate the technologies to the greatest extent 
possible, but also the groups working on those 
technologies.  Those groups include GRC, JSC, and 
ARC, as well as the NSBRI.  Relevant work being 
performed with non-NASA funding will be identified 
and NASA work will be leveraged with those efforts. 
imaging and image processing 
techniques be implemented with 
radiation-tolerant hardware/software 
that will survive the deep space 
radiation environment? 
 To what extent can pre- & postflight 
demonstrations of ground-based 
enabling imaging technologies, using 
flight crews as subjects, elucidate the 
development of flight technologies? 
4.03 Lack of capability to treat 
back/neck pain and injuries in 
the space flight environment 
This gap primarily addresses the possibility of a back 
or neck injury occurring during lunar surface 
exploration.  The type of injury will most likely be 
mild-to-moderate ligament or muscle strains. 
 What is the etiology of back/neck pain 
in space flight? 
 What space flight-friendly treatments 
are available for each source of 
back/neck pain? 
 How do we prevent back/neck injuries 
from occurring? 
4.04 Lack of smart hardware for 
ventilation with variable 
oxygenation capability that 
mitigates localized oxygen build 
up 
The proper and adequate operation of a ventilating 
device and variable oxygen delivery is a skill that takes 
many hours of training.  The Crew Medical Officers 
(CMO) on exploration missions will more than likely 
be given very limited medical training overall and even 
more limited training on ventilation and variable 
oxygen delivery.  The training opportunities to teach 
the CMO on how to operate a ventilator will not be 
adequate enough to provide terrestrial standard of care 
during a medical contingency. 
 
The purpose of this gap is to develop hardware that can 
assist the caregiver in decision support involved with 
operating a ventilator and variable oxygen delivery 




also be investigated in this gap should relevant medical 
conditions call for CO2 regulation.  The entire smart 
system will also need to minimize volume, mass, and 
power consumption.  Developing a smart hardware 
system reduces the cognitive burden on the CMO to 
operate the ventilator, thereby reducing the risk of an 
inadequately trained operator.  The smart hardware can 
manage the ventilation of the patient while the CMO 
performs other medical tasks.  This also allows CMO 
training to focus their limited resources on other 
aspects of their CMO training for tasks that technology 
cannot overcome. 
4.05 Lack of minimally invasive in-
flight laboratory capabilities 
with limited consumables 
required for diagnosing 
identified Exploration Medical 
Conditions 
Analyzing bodily fluids (urine, blood, saliva) on the 
exploration missions will reduce launch/return 
mass/volume and provide data in near real time in lieu 
of postflight results.  A system to perform this analysis 
in flight is necessary to meet these requirements.  
NASA conducted several trade studies analyzing the 
hardware available and developed an Excel-based tool 
to quantify the ability of hardware to meet mission 
requirements.  To reduce system mass and volume, 
NASA is investigating the development of concepts 
and hardware for reusable systems of this type. 
 
Such miniaturized systems are dependent upon space 
medical standards and requirements that will be 
determined based on expert opinion, risk assessments, 
and evidence bases.  These standards and requirements 
are critical for engineering and medically qualifying 
the appropriate system for remote space applications. 
Since no in-situ medical diagnostic device that involves 
blood or urine fluid analysis is currently operational, it 
will be important to establish that such a device may be 
operated routinely.  In addition to microfluidic 
processing systems, noninvasive monitoring devices 
may also be considered. 
 What conditions and/or measurements 
can be diagnosed with less invasive 
measurements (e.g., saliva, breath, 
sweat, interstitial fluid) or noninvasive 
measurements (e.g., optical, 
electromagnetic) through the skin? 
 Are less invasive measurements as 
effective as current blood- (or urine) 
based methods in terms of ease of use 
and reducing consumables?  
 What new measurement capability 
could be applied to further reduce 
consumables? 
 If blood measurement is necessary, are 
there emerging technologies that can be 
applied to provide a sample that would 




4.06 Lack of capability to stabilize 
and treat bone fractures 
Bone mineral loss occurs in microgravity due to 
unloading of the skeletal system, with average loss 
rates of approximately 1% per month.  It is unclear 
whether this bone mineral density will stabilize at a 
lower level or continue to diminish.  It is also unknown 
if fractional gravity, present on the moon and Mars, 
would mitigate the loss.  This level of bone loss does 
not create an unacceptable risk of fracture for ISS 
missions, but longer missions could create higher 
fracture risk (excerpt from the IRP). 
 
Current casting methods are problematic for the 
anticipated operational environment during lunar 
mission sorties and long-duration stays.  Modifying 
existing casting methods or identifying a new 
technology for casting is essential for meeting this gap. 
 How should long bone fractures be 
treated in micro and partial gravity? 
 How should short bone fractures be 
treated in micro and partial gravity? 
 How should flat bone fractures be 
treated in micro and partial gravity? 
 How should distal bone fractures be 
treated in micro and partial gravity? 
 Does stabilization hardware allow for 
proper personal hygiene for full 
duration of treatment in micro and 
partial gravity? 
4.07 Lack of wound care capability to 
improve healing following 
wound closure 
Explore the development of methods and technologies 
for wound care capabilities. 
 Is wound healing repressed in a space 
flight environment? 
 What technologies, techniques, or 
methods are available to accelerate 
wound healing? 
4.08 Lack of capability to treat 
muscle, ligament, and tendon 
injuries 
With longer missions and more labor intensive tasks 
expected during exploration missions, the likelihood of 
musculoskeletal injuries such as sprains and strains is 
expected to increase.  Standard terrestrial therapeutic 
response to treating sprains and strains is to provide 
cold compress or heat treatment to the affected area.  
Cold compress and/or heat treatment is desired that can 
be stowed in its inactive state in the vehicle's ambient 
environment, activated to provide the desired 
therapeutic relief, recharged using available vehicle 
resources, and restored in its inactive state for future 
use. 
 
4.09 Lack of medical suction and 
fluid containment capability for 
chest tube and airway 
There is currently no medical suction capability that 
would work in the space operational environment. 
Medical suction clears the airway, empties the 
 How should vacuum levels be adjusted 
for reduced gravity?  
 Will "pusher" fluids be required in 
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management stomach, decompresses the chest, and keeps the 
operative field clear. 
reduced gravity? 
4.10 Lack of rapid vascular access 
capability for space flight 
In a medical contingency, the ability to gain access to 
the patient's vascular system to provide medications or 
fluids can be critical.  This task is difficult to 
accomplish even for skilled medical care providers.  
This gap is focused on finding technologies or 
techniques that can allow a medical care provider to 
safely and rapidly establish vascular access in a patient 
that is easy for a layperson to operate, minimizes 
trauma, and minimizes the infection rate.  This 
assessment will consider conventional intravenous (IV) 
and intraosseous (IO) vascular access methods as 
potential treatment modalities. 
 Is there a technical solution, procedural 
solution, or both for gaining rapid 
vascular access during space flight? 
4.11 Lack of dental care capabilities Development of methods/technologies for dental 
conditions; technology development effort to provide 
dental care technology.   Future solicitation will not 
start until FY13. 
 
4.12 Lack of in situ intravenous (IV) 
fluid generation and resource 
optimization capability 
Medical operations concepts for both International 
Space Station (ISS) missions and exploration missions 
include pharmaceuticals that can only be given 
intravenously.  Additionally, several conditions may 
require intravenous fluid to maintain hydration and 
electrolyte balance.  Because of the volume and mass 
that would be required to treat all conditions specified, 
NASA prefers to generate sterile water for injection in 
situ on an ad hoc basis. Currently, no proven 
technology exists that can do this in a space flight 
environment. 
 What are the effects on the shelf life of 
solutions due to environmental radiation 
exposure to the container? 
 What is the maximum capacity of the 
system for each possible contaminant? 
 What packaging design should be used 
to enclose each purification system 
before use (to avoid contamination)? 
 What is the shelf life of the purification 
system as packaged?  
 What are the effects of temperature on 
stored system shelf life? 
 What are the effects of temperature on 
the operating systems filtering capacity? 
 What are the effects of microgravity on 




4.13 Lack of capability to diagnose 
and treat a renal stone 
Kidney stone formation and passage has the potential 
to greatly impact mission success and crewmember 
health during long-duration missions.  Alterations in 
hydration state (relative dehydration) and bone 
metabolism (increased calcium excretion) during 
exposure to microgravity may increase the risk of 
kidney stone formation and it is unclear which 
mitigation strategy would be the most effective. 
 
Lithotripsy is a medical procedure that uses shock 
waves to break up stones that form in the kidney, 
bladder, ureters, or gallbladder. 
 What cutting-edge technologies are 
being developed for the diagnosis and 
treatment of kidney stones, and how 
effective and flight-feasible are they?  
 Can a non-expert diagnose and treat 
kidney stones in a space operational 
environment? 
4.14 Lack of efficient medical 
consumable inventory tracking 
system that provides data on 
overall usage and usage rate and 
integrates securely with vehicle 
inventory management system 
When shuttle and ISS medical kits are returned to 
Earth, fewer medical consumables remain in the 
medical kits than would be expected based on reported 
use by the astronauts.  This gap is significant because 
the possibility exists that exploration missions could be 
undersupplied and run the risk of being unable to treat 
an ill or injured crewmember, particularly given the 
small volume available for the medical kits. 
Work under this gap will identify current practices, 
develop controls, processes, and technical solutions to 
accurately track the inventory of medical consumables 
including pharmaceuticals. 
 How do analog institutions track 
medical consumables to the dose level? 
 How do analog institutions handle 
privacy issues? 
 How do tracking technologies vary with 
storage requirements? 
 How do analog institutions track liquid 
medications to the dose level? 
4.15 Lack of a medication usage 
tracking system that includes 
automatic time stamping and 
crew identification 
When shuttle and ISS medical kits are returned to 
Earth, fewer medical consumables remain in the 
medical kits than would be expected based on reported 
use by the astronauts.  This gap is significant because 
the possibility exists that exploration missions could be 
undersupplied and run the risk of being unable to treat 
an ill or injured crewmember, particularly given the 
small volume available for the medical kits. 
  
Work under this gap will identify current practices, 
develop controls, processes, and technical solutions to 
accurately track the inventory of medical consumables 




4.16 Lack of technique or procedure 
to draw injectable medication 
into a syringe without bubble 
formation or bubble removal 
before medication delivery 
Preparation of injectable medications in a non-micro 
gravity environment simplifies removal of air bubbles 
within the syringe.  This luxury is lost in microgravity 
as isolation of bubbles becomes difficult due to the 
absence of a force greater than the surface tension of 
the medication.  The consequence of injecting an air 
bubble into a crewmember could be harmful.  This 
gap’s focus is to develop a technology or technique to 
prepare an injectable medication without air bubbles 
for safe delivery to a crewmember. 
 How can bubbles be prevented from 
entering the syringe under reduced 
gravity/pressure conditions? 
 How can bubbles be eliminated if 
introduced into the syringe under 
reduced gravity/pressure conditions?  
4.17 Lack of adequate protection for 
medications to preserve stability 
and shelf life during long 
duration space flight missions 
It is currently unknown how effectively the packaging 
of medications preserves the stability and shelf life of 
the contents from the effects of space flight.  Space 
flight adds the elements of microgravity and radiation 
that are not applicable on the surface of Earth.  This 
gap seeks to address materials or products that can 
mitigate space flight effects and assist in the 
preservation of medications. 
 How can the efficacy of medications be 
maintained in space flight environment?  
 Can medication efficacy be maintained 
beyond the manufacturer's expiration 
date? 
 What materials or 
packaging/preparation techniques can 
be used to maintain medication 
stability? 
 Is the efficacy of medications 
compromised during space flight? 
4.18 Lack of adequate biomedical 
monitoring capability for 
exploration EVA suits 
The crewmembers' physiological data, if monitored 
regularly, can indicate to the flight surgeons if there is 
a medical problem.  During EVAs and periodic 
intravehicular activities (IVA), the flight surgeons need 
the ability to monitor key physiological signals that 
indicate the crew's work load and other physiologic 
parameters.  The current system for donning the 
sensors is time consuming and inconvenient, requiring 
shaving, application of electrodes, and signal checks.  
A more efficient system will save crew time and reduce 
the overhead of stowing additional supplies.  This 
system will be achieved through the integration of 
small, easy to use biomedical sensors that will have the 
ability to measure, store, and transmit physiologic 
 What biomedical monitoring 
technologies can achieve an accurate 
and stable signal, maximize 
crewmember comfort, and minimize 
artifacts, consumables, and the time 
required for donning and doffing?  
 What do other operational groups (first 
responders, war fighters, high elevation 
climbers) do for biomedical monitoring?  
 What new biomedical monitoring 
technologies are available?  
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parameters during operational and ambulatory 
scenarios.  Such a system would also provide a wealth 
of data for the medical and research communities.   
Plans for overall medical and research biomedical 
sensing would be coordinated with the HHC element. 
4.19 Lack of biomedical monitoring 
capabilities for performing 
periodic clinical status 
evaluations and contingency 
medical monitoring 
The crewmembers' physiological data, if monitored 
regularly, can indicate to the flight surgeons if there is 
a medical problem.  During periodic IVA activities, the 
flight surgeons need the ability to monitor key 
physiological signals that indicate the crew's work load 
and other physiologic parameters.  The current system 
for donning the sensors is time consuming and 
inconvenient, requiring shaving, application of 
electrodes, and signal checks.  A more efficient system 
will save crew time and reduce the overhead of stowing 
additional supplies.  This system will be achieved 
through the integration of small, easy to use biomedical 
sensors that will have the ability to measure, store, and 
transmit physiologic parameters during operational and 
ambulatory scenarios.  Such a system would also 
provide a wealth of data for the medical and research 
communities.   Plans for overall medical and research 
biomedical sensing would be coordinated with the 
HHC element. 
 What biomedical monitoring 
technologies can achieve the required 
accuracy and stability during both 
ambulatory and contingency operations, 
while also minimizing consumables, 
inconvenience (shaving, skin prep), and 
time? 
 What biomedical monitoring system 
architecture/design (including mix of 
wired versus wireless, disposable versus 
reusable, autonomous versus assisted) 
would best meet the monitoring needs 
for the various Space Medicine 
Exploration Medical Condition List 
(SMEMCL) conditions, and for the 
expected usage rates for other non-
contingency activities? 
 What do other remote and resource-poor 
groups (submarines, Antarctic stations) 
do for periodic clinical status 
evaluations?  
 What new biomedical monitoring 
technologies are available?  
4.20 Lack of a system to manage 
medical data collected from the 
patient during space flight that 
integrates with ground 
operations 
A system needs to be developed to integrate and 
manage the medical data captured by the diagnostic 
and therapeutic devices in a manner such that the 
medical data and information will be available, secure, 
and at full integrity. 
 What should the architecture be for the 
integrative platform (e.g., black box, 
open format)? 
 How will the platform integrate existing 
medical records from preflight and 




 Will the medical data management 
system make medical action 
recommendations? 
4.21 Lack of adequate eye wash 
capability to treat chemical eye 
exposure in partial and 
microgravity environments 
Standard treatment of a chemical exposure to the eye 
involves a constant flushing of the eye with clean 
water.  The space flight and vehicle environment may 
not allow for constant flushing of the eye due to usage 
of valuable water resource and containment of the 
contaminated water after flushing.  Technology needs 
to be developed to allow for flushing of the affected 
eye(s) for the required period of time, minimizing 
overall water usage while being operable in the various 
gravity environments experienced during exploration 
missions. 
 How can a contaminant in the eye be 
rendered harmless? 
 What are viable methods for 
neutralizing a contaminant or removing 
contaminant/particulate matter from the 
eye, and how are the methods affected 
by partial and/or micro gravity? 
4.22 Lack of capability to treat 
radiation sickness 
Treatment of radiation sickness involves a broad scope 
of resources.  Most of these resources are available for 
space flight from a technical feasibility perspective.  
One treatment resource that has not been developed is 
blood products or substitutes to replace blood cells 
damaged by radiation sickness. 
 What new methods to diagnose and treat 
radiation sickness are being developed?  
 What research studies are required to 
demonstrate the safety and efficacy of a 
diagnosis and/or treatment method for 
radiation sickness? 
4.23 Lack of capability to auscultate 
internal sounds of the body in a 
space flight environment 
Analysis of body sounds for abnormalities is standard 
medical practice for diagnosing a medical condition.  
This gap addresses the need to isolate internal body 
sounds in a potentially noisy ambient environment and 
capture the auscultation data to be managed and 
transmitted to the appropriate destination for analysis. 
 Are there technological 
improvements/innovations to key 
stethoscope components that can 
improve current instrument 
performance? 
 Are there options besides auscultation 
(e.g., ultrasound) that can be used to 
listen to the internal sounds of the body? 
4.24 Lack of knowledge to treat 
conditions on the Exploration 
Medical Condition List in 
remote resource-poor 
environments 
This gap seeks to understand how medical conditions 
are treated in the remote parts of planet Earth.  These 
environments have similar operational constraints in 
that resources are limited.  Understanding how medical 
care is conducted in these locations will aide in the 
development of a medical system for the remote 
environment of outer space. 
 Is our method of treatment for each of 
the medical conditions on the SMEMCL 
consistent with how similar conditions 




4.25 Lack of capability to deliver 
medication to crewmember in 
pressurized suits 
Given the possibility that vehicle failures could result 
in the crew needing to remain in pressurized suits for 
up to 144 hours, and given that medical operations may 
need to provide medications via injection during that 
time, NASA must develop reliable methods for 
delivering such medications through the suit.  A key 
assumption is, if the crew is in their suits, the cabin 
atmosphere is likely to be absent or at a greatly reduced 
pressure.  Such a condition could lead to bubbles in the 
medication and pharmaceutical freezing. 
 
4.26 Lack of knowledge for treating 
pulmonary or systemic disease 
due to non-terrestrial dust 
exposure 
The goal of this gap is to understand the effects of 
short- and long-term exposure to nonterrestrial dust on 
human systems and develop treatments to mitigate the 
effects. 
 What symptoms do the body systems 
exhibit when exposed to lunar dust? 
 Do conventional treatments work as 
effectively on symptoms of lunar dust 
exposure?  
5.01 Lack of medical data 
management infrastructure for 
Exploration Missions 
In space flight, there is a large amount of data 
generated to understand and monitor the health and 
safety of the crewmember.  Because of the large 
volume of data, a data management infrastructure 
needs to be deployed to allow users access to the data.  
The system needs to be available, secure, and ensure 
data integrity.  Users can gain valuable insight into the 
health and safety of the crew to maintain their health 
status and ensure mission success. 
 
 
